ELB-021
N/A
Report date: 2024/10/31 11:05:30
Base Information
Drug NameELB-021
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElsalys Biotech
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A